IL234116B - Composition having sialidase activity for treatment of parainfluenza virus in immunocomprimised patients - Google Patents
Composition having sialidase activity for treatment of parainfluenza virus in immunocomprimised patientsInfo
- Publication number
- IL234116B IL234116B IL234116A IL23411614A IL234116B IL 234116 B IL234116 B IL 234116B IL 234116 A IL234116 A IL 234116A IL 23411614 A IL23411614 A IL 23411614A IL 234116 B IL234116 B IL 234116B
- Authority
- IL
- Israel
- Prior art keywords
- deficiency
- patients
- preparation
- treatment
- immune system
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/12—Mucolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01018—Exo-alpha-sialidase (3.2.1.18), i.e. trans-sialidase
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Otolaryngology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261600545P | 2012-02-17 | 2012-02-17 | |
| US201261727627P | 2012-11-16 | 2012-11-16 | |
| PCT/US2013/026754 WO2013123521A1 (en) | 2012-02-17 | 2013-02-19 | Methods, Compounds and Compositions for Treatment of Parainfluenza Virus in Immunocompromised Patients |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL234116B true IL234116B (en) | 2020-03-31 |
Family
ID=48984833
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL234116A IL234116B (en) | 2012-02-17 | 2014-08-13 | Composition having sialidase activity for treatment of parainfluenza virus in immunocomprimised patients |
| IL273194A IL273194B2 (en) | 2012-02-17 | 2020-03-10 | Methods, compounds and preparations for the treatment of parainfluenza virus in patients with a deficiency in the immune system |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL273194A IL273194B2 (en) | 2012-02-17 | 2020-03-10 | Methods, compounds and preparations for the treatment of parainfluenza virus in patients with a deficiency in the immune system |
Country Status (9)
| Country | Link |
|---|---|
| US (5) | US20130280332A1 (enExample) |
| EP (1) | EP2841092B1 (enExample) |
| JP (1) | JP2015508780A (enExample) |
| CN (2) | CN109529026A (enExample) |
| AU (3) | AU2013221230A1 (enExample) |
| CA (1) | CA2864746A1 (enExample) |
| ES (1) | ES2970401T3 (enExample) |
| IL (2) | IL234116B (enExample) |
| WO (1) | WO2013123521A1 (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103180318B (zh) | 2010-05-14 | 2017-05-10 | 达那-法伯癌症研究所 | 雄性避孕组合物以及使用方法 |
| ES2606958T3 (es) | 2010-05-14 | 2017-03-28 | Dana-Farber Cancer Institute, Inc. | Compuestos de tienotriazolodiazepina para tratar una neoplasia |
| CN103154246B (zh) | 2010-05-14 | 2015-11-25 | 达那-法伯癌症研究所 | 用于治疗白血病的组合物和方法 |
| BR112016001457A2 (pt) | 2013-07-25 | 2017-08-29 | Dana Farber Cancer Inst Inc | Inibidores de fatores de transcrição e usos dos mesmos |
| US11446309B2 (en) | 2013-11-08 | 2022-09-20 | Dana-Farber Cancer Institute, Inc. | Combination therapy for cancer using bromodomain and extra-terminal (BET) protein inhibitors |
| MX2016009974A (es) | 2014-01-31 | 2016-10-31 | Dana Farber Cancer Inst Inc | Derivados de diaminopirimidina bencensulfona y sus usos. |
| EP3099693A4 (en) | 2014-01-31 | 2017-08-16 | Dana-Farber Cancer Institute, Inc. | Uses of diazepane derivatives |
| WO2015131113A1 (en) | 2014-02-28 | 2015-09-03 | Tensha Therapeutics, Inc. | Treatment of conditions associated with hyperinsulinaemia |
| RU2017104897A (ru) | 2014-08-08 | 2018-09-10 | Дана-Фарбер Кэнсер Инститьют, Инк. | Производные диазепана и их применения |
| WO2016022970A1 (en) | 2014-08-08 | 2016-02-11 | Dana-Farber Cancer Institute, Inc. | Dihydropteridinone derivatives and uses thereof |
| UA122130C2 (uk) | 2014-10-27 | 2020-09-25 | Тенша Терапеутікс, Інк. | Інгібітори бромодомену |
| CA2964629A1 (en) | 2014-11-06 | 2016-05-12 | Dana-Farber Cancer Institute, Inc. | Ezh2 inhibitors and uses thereof |
| BR112017009440A2 (pt) * | 2014-11-06 | 2017-12-19 | Dana Farber Cancer Inst Inc | uso de composições que modulam a estrutura de cromatina quanto à doença do enxerto versus hospedeiro (gvhd) |
| WO2016200916A1 (en) * | 2015-06-08 | 2016-12-15 | Ansun Biopharma, Inc. | Treatment of human metapneumovirus |
| CA2986441A1 (en) | 2015-06-12 | 2016-12-15 | Dana-Farber Cancer Institute, Inc. | Combination therapy of transcription inhibitors and kinase inhibitors |
| RU2018112953A (ru) | 2015-09-11 | 2019-10-14 | Дана-Фарбер Кэнсер Инститьют, Инк. | Ацетамидтиенотриазолодиазепины и пути их применения |
| US11306105B2 (en) | 2015-09-11 | 2022-04-19 | Dana-Farber Cancer Institute, Inc. | Cyano thienotriazolodiazepines and uses thereof |
| CR20180336A (es) | 2015-11-25 | 2018-08-06 | Dana Farber Cancer Inst Inc | Inhibidores de bromodominio bivalentes y usos de los mismos |
| WO2017184999A1 (en) | 2016-04-22 | 2017-10-26 | Dana-Farber Cancer Institute, Inc. | Ezh2 inhibitors and uses thereof |
| AU2020391178A1 (en) * | 2019-11-25 | 2022-06-09 | Ansun Biopharma, Inc. | Immune cell delivery of sialidase to cancer cells, immune cells and the tumor microenvironment |
| JP2024540218A (ja) | 2021-11-02 | 2024-10-31 | アンサン バイオファーマ， インコーポレイテッド | Ｄａｓ１８１バリアント組成物 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7334580B2 (en) * | 2002-05-07 | 2008-02-26 | Smaldone Gerald C | Methods, devices and formulations for targeted endobronchial therapy |
| EP1539284B1 (en) * | 2002-09-06 | 2020-01-29 | Philip Morris Products S.a.s. | Aerosol generating device and method for generating aerosols |
| US7807174B2 (en) * | 2002-11-22 | 2010-10-05 | Nexbio, Inc. | Class of therapeutic protein based molecules |
| AU2003294401C1 (en) | 2002-11-22 | 2008-09-18 | Ansun Biopharma, Inc. | Broad spectrum anti-viral therapeutics and prophylaxis |
| WO2007114881A1 (en) * | 2006-01-24 | 2007-10-11 | Nexbio, Inc. | Technology for preparation of macromolecular microspheres |
| AU2010315024B2 (en) * | 2009-11-06 | 2015-02-12 | Nexbio, Inc. | Methods, compounds and compositions for treatment and prophylaxis in the respiratory tract |
-
2013
- 2013-02-19 WO PCT/US2013/026754 patent/WO2013123521A1/en not_active Ceased
- 2013-02-19 US US13/770,991 patent/US20130280332A1/en not_active Abandoned
- 2013-02-19 CA CA2864746A patent/CA2864746A1/en not_active Abandoned
- 2013-02-19 JP JP2014557870A patent/JP2015508780A/ja active Pending
- 2013-02-19 CN CN201811368987.7A patent/CN109529026A/zh active Pending
- 2013-02-19 AU AU2013221230A patent/AU2013221230A1/en not_active Abandoned
- 2013-02-19 EP EP13749329.2A patent/EP2841092B1/en active Active
- 2013-02-19 ES ES13749329T patent/ES2970401T3/es active Active
- 2013-02-19 CN CN201380009763.6A patent/CN104203267A/zh active Pending
-
2014
- 2014-08-13 IL IL234116A patent/IL234116B/en active IP Right Grant
-
2015
- 2015-01-26 US US14/605,572 patent/US20150132274A1/en not_active Abandoned
-
2017
- 2017-02-10 US US15/430,288 patent/US20170151315A1/en not_active Abandoned
- 2017-11-10 AU AU2017258955A patent/AU2017258955A1/en not_active Abandoned
-
2019
- 2019-09-05 AU AU2019226190A patent/AU2019226190B2/en not_active Ceased
-
2020
- 2020-03-10 IL IL273194A patent/IL273194B2/en unknown
- 2020-07-31 US US16/945,776 patent/US20210046165A1/en not_active Abandoned
-
2025
- 2025-01-21 US US19/033,237 patent/US20250387457A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2019226190B2 (en) | 2021-10-07 |
| CN109529026A (zh) | 2019-03-29 |
| IL273194B2 (en) | 2023-02-01 |
| US20130280332A1 (en) | 2013-10-24 |
| AU2019226190A1 (en) | 2019-09-26 |
| AU2013221230A1 (en) | 2014-10-02 |
| EP2841092A4 (en) | 2015-09-16 |
| AU2017258955A1 (en) | 2017-12-14 |
| US20210046165A1 (en) | 2021-02-18 |
| EP2841092C0 (en) | 2023-12-06 |
| JP2015508780A (ja) | 2015-03-23 |
| HK1207975A1 (en) | 2016-02-19 |
| EP2841092A1 (en) | 2015-03-04 |
| ES2970401T3 (es) | 2024-05-28 |
| US20250387457A1 (en) | 2025-12-25 |
| US20170151315A1 (en) | 2017-06-01 |
| CN104203267A (zh) | 2014-12-10 |
| IL273194B (en) | 2022-10-01 |
| WO2013123521A1 (en) | 2013-08-22 |
| US20150132274A1 (en) | 2015-05-14 |
| IL273194A (en) | 2020-04-30 |
| CA2864746A1 (en) | 2013-08-22 |
| EP2841092B1 (en) | 2023-12-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL273194B (en) | Methods, compounds and compositions for treatment of parainfluenza virus in immunocompromised patients | |
| IL275998B (en) | Medical system | |
| EP2803342A4 (en) | COLLECTOR FOR HUMAN FACIALS | |
| DK2641614T3 (da) | Farmaceutisk præparat integreret med mikronåle til hudbehandling | |
| EP2680775A4 (en) | Cryogenic medical system | |
| DK3335652T3 (da) | Medicinsk fastgørelseselement | |
| DK2793965T3 (da) | Vævsprodukter med flydeevne | |
| IL235512B (en) | Phenylbenzamide derivatives for use in treating diseases mediated by aquaporin | |
| EP2916905A4 (en) | MEDICAL CONNECTOR | |
| EP2842540A4 (en) | MEDICAL CONNECTOR | |
| HRP20181378T1 (hr) | Postupci liječenja pedijatrijskih pacijenata deksmedetomidinom | |
| EP2755720A4 (en) | SYSTEMS AND METHODS FOR THE THERAPY OF SLEEP APNEA | |
| IL228649B (en) | Immunogenic compositions for use in therapy | |
| BR112013019091A2 (pt) | sistema de tratamento de tecido | |
| BR112015004072A2 (pt) | sistema de preensão de artigo médico para prender um artigo médico | |
| KR102245694B9 (ko) | 기계식 체결구, 체결 시스템, 및 일회용 흡수 용품 | |
| IL230992B (en) | Blood pump systems and methods | |
| BR302012004766S1 (pt) | Configuracao aplicada em injetor médico | |
| BR302012005886S1 (pt) | Configuração aplicada em adesivo médico | |
| IL231120A0 (en) | Implantable medical devices with increased immune tolerance, and methods for making and implanting | |
| IL235768A0 (en) | Pharmaceutical compositions and treatment of mastitis | |
| EP2758019A4 (en) | PATIENT / DISABILITY CARRIER | |
| DK2890428T3 (da) | Medicinsk anordning med slagfast hus | |
| GB201215012D0 (en) | Patient repositioning system | |
| HUE037274T2 (hu) | In vivo tumorellenes aktivitással rendelkezõ, humán DLK-1 elleni antitest |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed |